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Abstract
Background: The aim of the work is the application of a bolus tracking technique for tomographic evaluation of
the uretero-vesicular junction in dogs. Ten adult dogs (8–14 years) with variable body weight (2,8–32 kg) were
enrolled in the prospective study. The patients were placed in sternal recumbency with a 10° elevated pelvis and
the visualization of the uretero-vesicular junction was obtained with the bolus tracking technique after intravenous
administration of non-ionic contrast medium. In the post-contrast late phase a region of interest was placed within
the lumen of the distal ureters and the density values were monitored before starting the helical scan.
Results: The uretero-vesicular junction was clearly visible in 100 % of patients with the visualization of the endoluminal
ureteral contrast enhancement and bladder washout. At the end of the tomographic study an evaluation of the dose
records was performed and compared to human exposures reported in literature for the pelvic region. The effective
dose estimated for each patient (37,5–138 mSv) proved to be elevated, when compared to those reported in human
patients.
Conclusion: The bolus tracking technique could be applied for the visualization of the uretero-vesicular junction in
non-pathological patients, placing the region of interest in the distal ureters. The high effective doses recorded in our
study support the need of specific thresholds for veterinary patients, pointing out the attention for paediatric patient’s
exposure also in veterinary imaging.
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Background
Ureteral ectopia is a pathological condition that occurs
as a result of abnormal caudal migration of the ureteral
bud at the level of its insertion to the urinary bladder
[1]. This pathological condition, widely represented both
in humans and animals, can lead to severe mechanical
obstruction with consequent hydroureter, hydronephro-
sis and pyelectasis in chronic and more severe stages of
the disease. Computed tomography has been considered
the modality of choice for the evaluation of the pelvic
region, avoiding superimposition of structures, limited
contrast and spatial resolution. Computed tomography
Excretory Urography (CTEU), dynamic scans of the pel-
vic region, has been reported [2–8] as a useful tool to
evaluate the distal ureteral jet of the contrast media.
Moreover, the administration of complementary drugs,
such as furosemide, or different patients positioning, su-
pine vs sternal, for the optimization of the visualization
of the distal portion of the ureters has been well investi-
gated [7–12].
Because of the difficulty to correctly visualise the
uretero-vesicular junction, very often many repeated hel-
ical CT scans of the pelvic region are required, strongly in-
creasing patient exposure. In order to achieve qualitative
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images of the uretero-vesicular junction, optimizing scan-
ning time delay is mandatory, although it could be widely
different among patients [7, 8].
The aim of this work was to evaluate the feasibility to
use the bolus tracking technique to visualize the
uretero-vesicular junction in dogs. Additionally, an esti-
mation of the exposure parameters was performed.
Methods
Dogs referred to our Institution for neoplasms staging
and without signs of urinary tract illness have been
enrolled in the prospective study. Premedication was
not standardized. In all dogs, anaesthesia was induced
with propofol and maintained by isoflurane in oxygen
100 % (Table 1).
Images were acquired using a 16-slices CT scanner
(GE Brightspeed®, GE Healthcare Milano - Italy). Dogs
were examined in sternal recumbency with the pelvis el-
evated on a wedge with a 5° to 10° angle [13]. CT
acquisition parameters, according to patient dimensions,
were set as follows: 120 kV, 150–200 mA, 1,25 mm thick
contiguous slices.
For contrast enhanced CT images, a bolus injec-
tion of a non-ionic iodinated contrast medium, Ioex-
hol (Omnipaque® 350 mg/ml, GE Healthcare Milano
- Italy) was administered into the cephalic vein via
18–27 G catheter at a dose of 600mgI/kg, using a
pressure injector (Medrad® Mark V Plus, Milano -
Italy) and a rate of 2–3 ml/s.
The acquisition protocol was as follows: 1) total body
CT scan; 2) contrast enhanced total body CT scan; 3)
post contrast late phase limited to the abdomen, using
the bolus tracking on the ureters.
Contrast medium was injected into the patient and a
ROI was positioned on the distal third of the ureteral
lumen, cranial to the caudo-medial deflection, in order
to track the volume of contrast (Fig. 1). CT images were
acquired, according to literature, after the 150 HU level
Table 1 Breed, Weight, Age, Sex, CT indication and Anaesthetic Protocols
Breed Weight (kg) Age (years) Sex CT indication Anaesthetic protocol
Akita 30 13 NF rectal neoplasm I: dex 3 μg/kg e.v. + ppf ̴ 2,5 mg/kg e.v.
M: iso in oxygen 100 %
Pinscher 6 14 IM bone neoplasm I: dex 3 μg/kg e.v. + ppf ̴ 2,5 mg/kg e.v
M: iso in oxygen 100 %
Mixed breed 5,5 8 IM suspected hepatic neoplasm I: dex 3 μg/kg e.v. + ppf ̴ 2,5 mg/kg e.v.
M: iso in oxygen 100 %
Irish Setter 26 8 NF mammary neoplasm I: dex 3 μg/kg e.v. + ppf ̴ 2,5 mg/kg e.v
M: iso in oxygen 100 %
Labrador Retriever 32 10 NF hepatic/splenic neoplasm P: dex 1 μg/kg e.v + but 0,2 mg/kg e.v.
I: ppf e.v. to effect ( ̴ 4 mg/kg)
M: iso in oxygen 100 %
Pinscher 5 8 IF mammary neoplasm P: dex 5 μg/kg i.m. + met 0,2 mg/kg i.m.
I: ppf ̴ 2,5 mg/kg e.v
M: iso in oxygen 100 %
Mixed breed 30 11 IF mammary neoplasm P: dex 5 μg/kg i.m. + met 0,2 mg/kg i.m.
I: ppf e.v. to effect ( ̴ 4 mg/kg)
M: iso in oxygen 100 %
Pinscher 2,8 8 IF mammary neoplasm P: dex 10 μg/kg i.m. + but 0,2 mg/kg i.m.
I: ppf e.v. to effect ( ̴ 4 mg/kg)
M: iso in oxygen 100 %
Pug 11 12 IM mandibular neoplasm P: but 0,2 mg/kg e.v.
I: ppf e.v. to effect ( ̴ 4 mg/kg)
M: iso in oxygen 100 %
English Setter 20 10 IF mammary neoplasm P: dex 5 μg/kg i.m. + met 0,2 mg/kg i.m.
I: ppf e.v. to effect ( ̴ 4 mg/kg)
M: iso in oxygen 100 %
NF neutered female, IM intact male, IF intact female, P premedication, I induction, M maintenance, ppf propofol, dex dexmedetomidine, iso isoflurane, but
butorphanol, met methadone
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was reached into the ROI [14]. During the monitoring
phase, low exposure (50 mA) repeated axial scans were
performed at the pre-selected level (Fig. 1). By means of a
built-in software program a near instantaneous time at-
tenuation curve was generated. When contrast medium
reached the desired 150 HU (Fig. 1) the operator triggered
a complete helical scan of the caudal abdomen.
Lactated Ringer’s solution was infused during anaesthesia
at a rate of 5 ml/kg/h to prevent contrast medium induced
acute kidney injury (CI-AKI) [15, 16].
Dose reports were stored for each acquired CT image
series. Images have been evaluated using a certified software
64 bit OsirixMED® (Aycan Medical System, LLC) and the
identification of the uretero-vesicular junction was assessed
for each patient in transverse slices, dorsal and longitudinal
reconstructions (Volume Rendering, Multiplanar Reforma-
tion and Maximum Intensity Projection).
The scans of interest for the evaluation of the ureteral
junction (conventional unenhanced and enhanced series,
low exposure axial series and late enhanced series with
bolus tracking technique) were selected from the Dose
Report of each dog. The Dose Length Product (DLP)
values for each scan were added together in order to ob-
tain an estimated total DLP value for each dog. Using
the formulas suggested in the AAPM 96 report [17] the
effective dose for each scan was calculated by multiply-
ing the DLP by the corrected conversion factor. In par-
ticular conversion factors of different human sizes
(0 year old, 1 year old, 5 years old, 10 years old and
adult) based on patient weight were used (Table 2).
Results
Ten dogs of different breeds (4 intact females, 3 neu-
tered females, 3 intact male) were enrolled. Body weight
varied from 2,8 to 32 kg (mean 16,83 kg) and the mean
age was 10,2 years, ranging from 8 to 14 years. All dogs
had no history or signs of urinary tract illness, based on
blood tests and pre-anaesthetic clinical evaluation.
The uretero-vesicular junction, was easily identified in
all (100 %) patients in the late bolus tracking scans, and
clearly visualized when the MIP post-processing tech-
nique was adopted (Figs. 2 and 3).
Based on Dose reports the volumetric computed tom-
ography dose index (CTDI vol) values, both partial and
total dose length product (DLP) values and effective
doses were estimated (Table 2). The effective dose range
was quite wide due to different patient weights. In par-
ticular the average effective dose for the pelvic region ac-
quisition was 20.1 ± 11.9 mSv (range 3.1–45.6 mSv) and
average effective dose, considering the whole protocol,
was 74.8 ± 25.6 mSv (range 37.5–138 mSv).
Discussion
The bolus tracking technique is a tomographic modality
of bolus contrast synchronization widely applied in hu-
man medicine, mainly for the examination of the cardio-
circulatory system and perfusion index of neoplasms, es-
pecially located in the liver [18, 19]. Bolus tracking tech-
nique allows a real time monitoring of the contrast
bolus by selecting a region of interest commonly posi-
tioned in the lumen of a vessel [18]. To the author's
Fig. 1 Transverse image at the level of the distal third of the right ureteral lumen, cranial to the caudo-medial deflection. Positioning of the ROI
(red arrow and circle) and tracking of the progressive intraluminal peak enhancement (HU enhancement/elapsed time diagram)
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Table 2 CTDI Vol, Partial and Total DLP, DPL Refined with Human Pelvis Weighing Factor
Breed Weight
(kg)
(reference
man)
Scan CTDI
vol
(mGy)
DLP Human
pelvis
weighing
factor
Effective
dose
(mSv)
(mGy-cm)
Akita 30 (10 yo) CU 19.93 2002,77 0,015 30,0
CE 19.93 2002,77 30,0
SA 29.17 29,17 0,4
LEBT 19.93 906,5 13,6
4941,21 74,1
Pinscher 6 (1 yo) CU 22.30 889,9 0,03 26,7
CE 22.30 889,9 26,7
SA 66.67 66,67 2,0
LEBT 22.30 103,8 3,1
1950,27 58,5
Mixed breed 5.5 (1 yo) CU 18.94 894,31 0,03 26,8
CE 18.94 894,31 26,8
SA 45.84 45,84 1,4
LEBT 18.94 894,31 26,8
2728,77 81,9
Irish Setter 26 (10 yo) CU 19.93 1305,14 0,015 19,6
CE 19.93 709,67 10,6
SA 29.17 29,17 0,4
LEBT 19.93 458,02 6,9
2502 37,5
Labrador Retriever 31 (10 yo) CU 21.71 2200,23 0,015 33,0
CE 21.7 2200,23 33,0
SA 33.34 33,34 0,5
LEBT 19.93 874,11 13,1
5307,91 79,6
Pinscher 5 (1 yo) CU 19.93 799,36 0,03 24,0
CE 19.93 799,36 24,0
SA 12.50 12,5 0,4
LEBT 19.93 799,36 24,0
2410,58 72,3
Mixed breed 30 (10 yo) CU 19.93 1397,33 0,015 21,0
CE 19.93 1397,33 21,0
SA 12.50 12,5 0,2
SA 12.50 29,17 0,4
LEBT 19.93 1397,33 21,0
4233,66 63,5
Pinscher 2,8 (0 yo) CU 17.94 930,21 0,049 45,6
CE 17.94 930,21 45,6
SA 25.00 25 1,2
LEBT 17.94 930,21 45,6
2816,63 138,0
Pug 11 (5 yo) CU 19.93 1193,02 0,02 23,9
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Table 2 CTDI Vol, Partial and Total DLP, DPL Refined with Human Pelvis Weighing Factor (Continued)
CE 19.93 1193,02 23,9
SA 12.50 12,5 0,3
LEBT 19.93 1193,02 23,9
3591,56 71,8
English Setter 20 (5 yo) CU 19.93 1153,16 0,02 23,1
CE 19.93 1153,16 23,1
SA 54.17 54,17 1,1
SA 25.00 25 0,5
LEBT 19.93 1153,16 23,1
3538,65 70,8
NF neutered female, IM intact male, IF intact female, CU conventional unenhanced, CE conventional enhanced, SA single axial, LEBT late enhanced with bolus
tracking technique
Fig. 2 Transverse images at the level of the uretero-vesicular junction. Gradual distribution of the contrast media: unhenhanced conventional scan (a),
vascluar distribution in the enhanced conventional scan (b), late post-contrast enhanced series with bolus tracking technique (c), reconstructed by MIP
(d). Black arrows indicate the uretero-vesicular junction
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knowledge, the visualization of the uretero-vesicular
junction by placing a ROI into the ureteral lumen has
never been reported before.
The need to apply this dynamic scan technique to the urin-
ary tract has been inspired by the everyday time-consuming
radiographic and tomographic examination of the excretory
apparatus in veterinary patients, as in case of CTEU or com-
bined intravenous pyelogram (IVP) and CT. This kind of stud-
ies can be strongly influenced by many variables, such as
patient dimensions, body weight, total blood volume, heart
rate and contrast medium [20]. These parameters, highly vari-
able in physiological conditions, may differ even more when
pathological conditions occur, such as ureteral ectopia, and
when anaesthetic drugs are administered [21, 22].
In this study the bolus tracking technique has been ap-
plied in dogs with no signs of urinary tract illness, in
order to verify its application on this apparatus in nor-
mal conditions. The uretero-vesicular junction was rec-
ognisable as a hook-shaped structure corresponding to
the medial deflection of the distal ureters as they insert
in the bladder wall [23]. It was easily identified in all pa-
tients in the late bolus tracking scans and better visual-
ized when the MIP post-processing technique was used.
Some authors indicated coronal views for humans as the
best reconstructions to allow a successful visualization
of the distal ureters without MIP, since this technique is
reported to reduce the density values of the enhanced
ureters in humans [3]. Our results are partially in agree-
ment with those previously reported: we observed a
slight enhancement reduction using MIP but this did
not influence the ability of the radiologist in the thor-
ough visualization of the uretero-vesicular junction. This
could probably lead back to the anatomical difference of
the abdominal anatomical shape between humans and
animals, more compressed dorso-ventrally in non-obese
people than in animals, where it usually develops in a
circular transverse shape. For this reasons it could be
easier to obtain a coronal reconstruction of the caudal
abdomen in humans, for a correct estimation of the
uretero-vesicular junction because in the same plane
coronal images can provide the appearance of both kid-
neys and ureters.
The application of the bolus tracking technique by
selecting a ROI in the ureteral lumen allows bypassing
most of the above-quoted issues, clearly visualizing the
uretero-vesicular junction, in normal conditions. More-
over, our study shows that the bolus tracking technique
can be successfully applied despite different anaesthetic
protocols as the uretero-vesicular junction is clearly vi-
sualized. Further studies will be required in the future to
evaluate the applicability of the bolus tracking technique
in patients with urinary tract illness and after the admin-
istration of other pre-anesthetic and anesthetic drugs.
An additional pressing problem, as far as the radio-
graphic and tomographic exam of the pelvis is con-
cerned, could be patient exposure [4, 5]. X-rays are
accountable for both deterministic and stochastic effects
[24–26] and precise thresholds are available for humans
[25]. Many authors [4, 5, 9] evaluated human patients
exposure during CT pelvic exams, but no evaluation has
ever been proposed for veterinary patients: this was the
second aim of this study. Patients exposure was esti-
mated choosing the appropriate scan series in the dose
report of each patient, and later refining them with the
application of human pelvis weighing factors (Table 2).
The estimation of the effective doses to pelvis turned
Fig. 3 Post-contrast sagittal 3D MIP of the abdomen showing the enhanced uretero-vesicular junctions and the ureteral washout
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out to be quite elevated if compared to human reported
values [2–8] but it must be taken into account that these
values could be affected by the weighting factors related
to human references and that the acquisition protocol
parameters are not optimized for dose reduction pur-
poses. However, the effective doses we estimated were in
any case well away from deterministic human damage
thresholds and never got closed to stochastic damage
thresholds either. Furthermore, the aim of this study was
also to demonstrate that the use of bolus tracking could
decrease patient exposure. Actually, the ability of this
technique to identify the optimal time delay for ureters
visualization, allows the reduction of patient dose by
avoiding useless exposures due to repeated acquisitions.
Conclusions
We consider the bolus tracking technique as a useful
tool to evaluate the distal portion of the ureters and the
uretero-vesicular junction in dogs without urinary tract
illness. This modality can enhance the visualization of
this region, possibly limiting the effective dose the pa-
tients receive from conventional uro-tomographic stud-
ies of the pelvis. Even if radio-exposure could be a
minor concern in veterinary patients, when compared to
humans, we would like to recommend a stressful atten-
tion to radio-exposure for this type of studies, not only
for the anatomical region exposed, but also for the high
prevalence of paediatric veterinary patients admitted for
this exams [26]. Future perspectives will be oriented to
the application of ureteral bolus tracking technique in
pathological conditions, taking into consideration the re-
duction of the effective doses for veterinary patients.
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